MENU
INVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Innoviva (INVA) Ownership - Who owns Innoviva?
Innoviva Inc is a company with a portfolio of royalties healthcare assets... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.32B
P/E Ratio
36.63
Total Cash
446.88M
Projected Growth
0.45
Total Debt
451.26M
Revenue
369.84M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
7.09
Total Debt/Equity
N/A
Revenue/Share
4.36 USD as % of share price
Fundamentals
INVA
Capitalization
1.32B
P/E Ratio
36.63
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
447M
Total Cash/Share
7.09
Total Debt
451M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
0.45
Revenue/Share (as % of the share price)
4.36%
Revenue
370M
ROE
N/A
Book Value
647M
P/B Ratio
1.84
Cash Flow
N/A
Earnings
-0.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
628K
Current Ratio
2.48
Current Revenue Per Employee
697889.75
Dividends Per Share - Security
0.00
EBITDA
681K
Float
N/A
Float - Current
N/A
Gross Income Margin
90.02
Revenue To Assets
-4.74
Shares Held By Institutions
6.38B
Shares Outstanding - Current
63M
Total Liabilities
607M
Total Volume MTD
N/A
Value
N/A
Gain YTD
20.576
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INVA showed earnings on August 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1350 Old Bayshore Highway
Phone
+1 650 238-9600
Employees
112
Web
https://www.inva.com